Metabolic and Inflammatory Proteins Differentially Expressed in Platelets
Total Page:16
File Type:pdf, Size:1020Kb
ics om & B te i ro o P in f f o o r l m a Journal of a n t r i Flores-Nascimento et al., J Proteomics Bioinform 2014, 7:1 c u s o J DOI: 10.4172/jpb.1000298 ISSN: 0974-276X Proteomics & Bioinformatics Research Article Article OpenOpen Access Access Metabolic and Inflammatory Proteins Differentially Expressed in Platelets from Unprovoked Deep Vein Thrombosis Patients Mariane C Flores-Nascimento1*, Karina Kleinfelder-Fontanesi2, Thiago Matos de Araújo3, Gabriel Forato Anhê3, Rodrigo Secolin4, Fernanda Andrade Orsi1, Erich Vinicius de Paula1 and Joyce M Annichino-Bizzacchi1 1Hematology-Hemotherapy Center, University of Campinas (UNICAMP), Campinas, SP, Brazil 2Biology Institute, University of Campinas (UNICAMP), Campinas, SP, Brazil 3Department of Pharmacology, University of Campinas (UNICAMP), Campinas, SP, Brazil 4Medical Genetic Department, University of Campinas (UNICAMP), Campinas, SP, Brazil Abstract Deep vein thrombosis (DVT) is multi-causal disease associated to high morbidity and mortality due to complications, especially from pulmonary embolism. New factors of relevance on the DVT pathophysiology enhance our understanding of disease mechanisms and can be translated into improved management of patients, prevention of recurrence and development of new therapies. In this context, the precise role of platelets in the pathogenesis of DVT is not completely understood. Our objectives were to acquire and to analyze the whole platelet protein profile of samples from 3 DVT patients and to compare them to results obtained from 1 sibling and 1 neighbor from each patient (in order to minimize genetic and environmental interferences). These patients presented unprovoked and recurrent episodes of proximal DVT as well as a family history of DVT. Platelets were washed, lysed, and the proteins were hydrolyzed by trypsin. Peptides were first separated by HPLC and peptide fractions were further detected by LC-MS/MS. Five proteins was present on patients and absent in all the controls: Apolipoprotein A1 Binding-Protein, Coatomer (zeta1 sub-unit), 17β-hydroxysteroid dehydrogenase type XI, Leukotriene A-4 Hydrolase and Sorbitol Dehydrogenase. The analysis identified proteins that currently are not related to the pathophysiology of DVT, and the persistence of these inflammatory and lipid transportation-related proteins emphasize the relevance of these phenomena on DVT. Keywords: Platelets; Deep vein thrombosis; Inflammation; Lipid proteins noticed that they could be useful in differentiating members of transportation; Metabolism a type I protein C deficiency family who has suffered thrombotic events before the age of 40 years from disease-free family members [8]. Introduction Platelets have a multitude of physiological functions, as the control Thrombosis is a multi-causal pathological process resulting from of haemostasis, the regulation of the vascular tone, the interaction the activation and propagation of the hemostatic response. Venous with leukocytes in inflammatory reactions, vascular repair and the thromboembolism (VTE) is considered a common disease, and its stimulation of cellular proliferation by the supply of growth factors incidence ranges from 1 to 3 cases per 1000 individuals [1,2]. In addition, [9]. Studies in platelet cytosolic proteome identified glycoproteins nearly 25% develop recurrent VTE within 10 years. Several hereditary and protein defects in patients with hereditary hemorrhagic diseases and acquired risk factors have been identified in the last two decades, [10] as well as after stimuli [11-15]. Microparticles from DVT patients but about 25% of patients present unprovoked deep vein thrombosis showed increased expressed (galectin-3 binding protein and alpha-2 (DVT), without known risk factor [3]. Additionally, patients with the macroglobulin) and depleted (fibrinogen beta and gamma chain same genetic alteration can present diverse clinical characteristics, precursors) proteins [16]. suggesting a possible interaction with other factors on DVT triggering. So, the identification of pathways involved on the pathophisiology of In this scenario, our objective was to acquire and to analyze the DVT would have great importance in clinical practice. whole platelet protein profile of samples from 3 high-selected patients with unprovoked and recurrent DVT, and to compare them to others Traditional coagulation tests, especially clot-based assays, are useful obtained from healthy siblings and neighbors. for describing major abnormalities on haemostatic response, but fail to assess thrombotic risk in the healthy population. Recent evidence also attests that the analysis of a vast array of genes can only explain a part of the individual thrombotic risk [4]. Thus, proteomic analysis may hold *Corresponding author: Mariane C Flores-Nascimento, Hematology- promise for characterizing or understanding biological pathways and Hemotherapy Center/University of Campinas (UNICAMP) P.O. Box 6198, 13083- pathophysiological interactions. To date, abnormal protein expression 970, Campinas - SP, Brazil, Tel: +55 19 3521 8601; Fax: +55 19 3289 1089; E-mail: profiles were identified by proteome approaches in patients with [email protected] increased risk of DVT. Our group previously performed a plasma Received November 12, 2013; Accepted January 20, 2014; Published January proteomic profile with the same individuals included in this study, and 24, 2014 verified that inflammatory, immune and lipid transportation proteins Citation: Flores-Nascimento MC, Kleinfelder-Fontanesi K, de Araújo TM, Anhê were differentially expressed [5]. Other recent findings included the GF, Secolin R, et al. (2014) Metabolic and Inflammatory Proteins Differentially Expressed in Platelets from Unprovoked Deep Vein Thrombosis Patients. J identification of one antithrombin variant (P80S) [6], which cannot be Proteomics Bioinform 7: 017-022. doi:10.4172/jpb.1000298 efficiently secreted from the hepatocyte, associated to loss of function. Copyright: © 2014 Flores-Nascimento MC, et al. This is an open-access article Gelfi et al. [7] verified increased level of glycosylation in carriers of the distributed under the terms of the Creative Commons Attribution License, which G20210A prothrombin mutation, which confer it a greater stability. permits unrestricted use, distribution, and reproduction in any medium, provided Another study performed on low molecular weight (500–20,000 Da) the original author and source are credited. J Proteomics Bioinform ISSN: 0974-276X JPB, an open access journal Volume 7(1) 017-022 (2014) - 017 Citation: Flores-Nascimento MC, Kleinfelder-Fontanesi K, de Araújo TM, Anhê GF, Secolin R, et al. (2014) Metabolic and Inflammatory Proteins Differentially Expressed in Platelets from Unprovoked Deep Vein Thrombosis Patients. J Proteomics Bioinform 7: 017-022. doi:10.4172/ jpb.1000298 Patients and Methods chromatograms was visually compared to others obtained from three runs of each individual included in a group of analyzes (one patient, Patients were recruited from the Outpatient Clinic of Hemocentro one sibling and one neighbor). As a similar variability was obtained de Campinas/UNICAMP between February 2009 and September 2009. in these comparisons, the subsequent runs were considered accepted. We selected 3 patients with recurrence of DVT episodes confirmed by Doppler ultrasonography, at least 6 months after withdrawal of warfarin The gradual release of the peptides from the column occurred therapy. Patients older than 50, with acquired or a known hereditary according to their affinity to a hydrophilic (A: 0.1% TFA) and a thrombophilia, cancer, myeloproliferative syndrome, liver or renal hydrophobic (B: 98% ACN/0.1% TFA) buffers. The fractions were disease were excluded. In order to minimize the environmental and collected in 8 intervals of 10 minutes each, from t=5 to t=85 min, and genetic influence in protein expression, two control groups composed frozen in liquid nitrogen. They were then lyophilized, resuspended in by siblings and individuals originated from the same geographic area 40 µL of 0.1% formic acid and directed to the hybrid mass spectrometer were included. These neighbors had no personal or familial history of LTQ-Orbitrap (Thermofisher Scientific, San Jose, CA, USA) and DVT, and were matched by gender, age (+/- 5 years), predominant auto-sampler coupled with a pump NanoLC (Eksigent Technologies, ethnic origin and tobaccoism. None of the patients and controls had Livermore, CA, USA). A second reverse phase chromatography was taken antiplatelet or anti-inflammatory drugs for 15 days before the performed on a nanocapillary column: 75 mm (I.D.) × 20 cm ProteoPep blood collection. This study was performed in accordance with the (New Objective®, Woburn, MA, USA). The buffer A consisted of Declaration of Helsinki and was approved by our local medical ethics 1% methanol/0.1% formic acid and the buffer B consisted of 1% committee. All patients and controls signed a written informed consent. methanol/0.1% formic acid/79% ACN and the runs comprised a 15 min. sample load at 3% B, and a 90 min. linear gradient from 5 to 45% Sample collection B. The mass spectrometer was set to repetitively scan m/z from 300 to Blood (24 mL) was drawn from the antecubital vein. The first sample 1800 (R=100,000 for LTQ-Orbitrap) followed by data-dependent MS/ was collected into a vacuum tube (Greiner Bio-One, Kremsmunster, MS scans on the six or ten most abundant ions, with a minimum signal Austria) containing EDTA and was directed to a blood count. The of